| Target Name | Substrate Name | Enz. Inhib. Data |
| 11-beta-Hydroxysteroid Dehydrogenase 1 (11-beta-HSD1) |
cortisone |
73 |
| [3H]-cortisone |
159 |
| [3H]cortisone |
26 |
| 11-beta-Hydroxysteroid Dehydrogenase 2 (11-beta-HSD2) |
cortisol |
42 |
| [3H]cortisol |
11 |
| 15-Lipoxygenase |
Linoleic Acid |
115 |
| 17-beta-Hydroxysteroid Dehydrogenase 1 (17-beta-HSD1) |
17beta-estradiol (E2) |
3 |
| Estrone (E1) |
3 |
| [2,4,6,7-3H]-E1 |
39 |
| 17-beta-Hydroxysteroid Dehydrogenase 2 (17-beta-HSD2) |
[2,4,6,7-3H]-E2 |
16 |
| 17-beta-Hydroxysteroid Dehydrogenase 5 (17-beta-HSD5, AKR1C3) |
3alpha-Androstanediol |
2 |
| Androstenedione |
3 |
| Androsterone |
2 |
| S-(+)-1,2,3,4-tetrahydro-1-naphthol |
1 |
| testosterone |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (H222S) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (L306A) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (L308A) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (L54V) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase (IspF) |
4-diphosphocytidyl-2C-methyl-D-erythritol-2-phosphate |
9 |
| 3-alpha-Hydroxysteroid Dehydrogenase Type 1 (AKR1C4) |
S-(+)-1,2,3,4-tetrahydro-1-naphthol |
1 |
| 3-alpha-Hydroxysteroid Dehydrogenase Type 3 (AKR1C2) |
S-(+)-1,2,3,4-tetrahydro-1-naphthol |
1 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) |
AKT2 |
75 |
| PDK1 Peptide Substrate |
1 |
| PDKtide |
11 |
| SGK1 |
50 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (A162V) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (E166D) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (L159M) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (T222A) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (V143T) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (V143T/T222A) |
PDKtide |
2 |
| 5-Lipoxygenase |
Arachidonic acid |
74 |
| Linoleic Acid |
28 |
| Abhydrolase Domain-Containing Protein 6 |
FP-rhodamine |
1 |
| ABL |
Biotinylated peptide substrate |
14 |
| biotinylated SB202190 |
7 |
| [Val5]-Angiotensin II |
30 |
| ABL Mutant (E255K) |
biotinylated SB202190 |
7 |
| ABL Mutant (F359V) |
biotinylated SB202190 |
7 |
| ABL Mutant (H396P) |
biotinylated SB202190 |
7 |
| ABL Mutant (M351T) |
biotinylated SB202190 |
7 |
| ABL Mutant (Q252H) |
biotinylated SB202190 |
7 |
| ABL Mutant (T315I) |
biotinylated affinity ligand |
20 |
| biotinylated SB202190 |
7 |
| ABL Mutant (T315N) |
biotinylated SB202190 |
7 |
| ABL Mutant (Y253F) |
biotinylated SB202190 |
7 |
| Acetylcholinesterase (AChE) |
acetylcholine |
93 |
| acetylcholine chloride |
15 |
| acetylthiocholine chloride |
15 |
| acetylthiocholine iodide |
873 |
| Activated Protein C (APC) |
Chromogenic Substrate S-2366 |
1 |
| Acyl Cholesterol Acyltransferase 1 (ACAT-1) |
[14C] oleoyl coenzyme A |
7 |
| ADAMTS-4 (Aggrecanase-1) |
Fluorescent peptide WAAG-3R |
30 |
| ADAMTS-5 (Aggrecanase-2) |
QF-peptide |
30 |
| WAAG-3R |
35 |
| Adenosine A3 Receptor |
[3H]AB-MECA |
29 |
| Adenosine Deaminase |
Adenosine |
59 |
| Adenosine Kinase (AK) |
Adenosine |
8 |
| Adenosine Phosphosulfate Reductase (APSR) |
Adenosine Phosphosulfate (APS) |
10 |
| Adenosine Receptor A1 |
Not Available |
71 |
| [3H]DPCPX |
103 |
| Adenosine Receptor A2A |
[3H]-CGS 21680 |
71 |
| [3H]-ZM241385 |
86 |
| [3H]NECA |
29 |
| Adenosine Receptor A2B |
Not Available |
7 |
| Adenosine Receptor A3 |
Not Available |
7 |
| AICAR Tfase |
AICAR |
19 |
| Aldehyde Reductase (ALR1) |
D,L-glyceraldehyde |
40 |
| Aldose Reductase (ALR2) |
benzyl alcohol |
15 |
| D,L-glyceraldehyde |
50 |
| D-glyceraldehyde |
77 |
| D-xylose |
4 |
| xylitol |
10 |
| Aldose Reductase (ALR2) Mutant (C298A) |
benzyl alcohol |
2 |
| Aldose Reductase (ALR2) Mutant (C298A/W219Y) |
xylitol |
12 |
| Aldosterone Synthase (CYP11B2) |
deoxycorticosterone |
94 |
| [4-14C]-11-deoxycorticosterone |
16 |
| Alpha-1 Adrenergic Receptor |
[3H]-Prazosin |
12 |
| alpha-Amylase |
Potato starch |
20 |
| alpha-Carbonic Anhydrase |
Carbon Dioxide |
17 |
| alpha-Chymotrypsin |
Not Available |
1 |
| alpha-Glucosidase (alpha-Glu) |
4-methylumbelliferyl alpha-glucoside |
14 |
| pNPG |
21 |
| alpha-Methylacyl-CoA Racemase |
(25S)-THC-CoA |
10 |
| Alpha2 Adrenoreceptor |
Clonidine |
4 |
| Aminopeptidase M |
L-alanyl-p-nitroanilide |
27 |
| L-Leucine-para-nitroanilide |
19 |
| Androgen Receptor (AR) |
DHT |
167 |
| Not Available |
27 |
| SRC2-3 peptide |
11 |
| Testosterone |
11 |
| [3H]DHT |
49 |
| [3H]MIB |
70 |
| Angiotensin-Converting Enzyme |
Abz-Gly-p-nitro-Phe-Pro-OH |
6 |
| Mca-Ala-Ser-Asp-Lys-Dpa-OH |
4 |
| N-Cbz-Phe-His-Leu |
29 |
| Angiotensin-Converting Enzyme 2 |
Mca-APK(Dnp)OH |
36 |
| Anthrax Lethal Factor (LF) |
fluorogenic LF protease substrate III |
21 |
| Fluorogenic LF Substrate |
28 |
| MAPKKide |
147 |
| Peptide Substrate |
50 |
| Apoptosis Regulator Bcl-2 |
FITC-conjugated-Bim BH3 Peptide |
10 |
| Fluorescein-labeled BAX peptide |
52 |
| Apoptosis Regulator Bcl-xL |
Bak-BH3 peptide |
19 |
| F-BakBH3 |
10 |
| F-Bim |
78 |
| Fl-Bak peptide |
50 |
| Fluorescein-labeled BAD peptide |
52 |
| Apurinic-Apyrimidinic Endonuclease 1 (APE1) |
DNA Substrate |
47 |
| Aromatase (CYP19) |
Androstenedione |
279 |
| dibenzylfluorescein (DBF) |
21 |
| Testosterone |
60 |
| [1beta-3H] androstenedione |
53 |
| Aryl Hydrocarbon Receptor (AhR) |
[3H]-TCDD |
25 |
| Asparaginyl Endopeptidase (AE) |
Cbz-Ala-Ala-Asn-AMC |
89 |
| ATP Phosphoribosyltransferase |
Phosphoribosyl Pyrophosphate (PRPP) |
11 |
| ATP-Binding Cassette Transporter ABCG2 |
PhA |
21 |
| Aurora Kinase A (Aurora-A) |
Aurora Peptide Substrate |
23 |
| biotinylated affinity ligand |
11 |
| Biotinylated Cross-tide Substrate |
13 |
| Biotinylated Peptide Substrate |
47 |
| CHOCKtide |
131 |
| FAM-PKAtide |
26 |
| Histone H3 |
84 |
| Kemptide |
1 |
| Not Specified |
1 |
| PKAtide |
2 |
| Substrate Peptide SerThr 01 |
1 |
| Aurora Kinase B (Aurora-B) |
Aurora B Substrate Peptide |
1 |
| biotinylated affinity ligand |
13 |
| Biotinylated Cross-tide Substrate |
13 |
| Biotinylated Peptide Substrate |
37 |
| CHOCKtide |
6 |
| FAM-PKAtide |
13 |
| Histone H3 |
16 |
| Not Specified |
1 |
| Aurora Kinase C (Aurora-C) |
biotinylated affinity ligand |
18 |
| Not Specified |
1 |
| AXL Receptor Tyrosine Kinase |
biotinylated affinity ligand |
16 |
| B-Raf Protein Kinase |
biotin-MEK |
1 |
| GST-MEK |
38 |
| GST-MEK1 |
16 |
| MEK-1 |
1 |
| Rhodamine green labeled ligand |
17 |
| B-Raf Protein Kinase Mutant (V599E) |
MEK-1 |
1 |
| B-Raf Protein Kinase Mutant (V600E) |
biotin-MEK |
13 |
| GST-MEK1 |
101 |
| MEK Inactive Mutant |
32 |
| Bacterial Leucyl Aminopeptidase |
L-Leucine-para-nitroanilide |
19 |
| Bacteriophage T4 DNA Ligase |
32P-labeled nicked duplex DNA substrate |
7 |
| Beta-1 Adrenergic Receptor |
[3H]CGP 12177 |
25 |
| Beta-2 Adrenergic Receptor |
[125I]-(-)iodopindolol |
7 |
| [3H]CGP 12177 |
32 |
| Beta-3 Adrenergic Receptor |
[3H]CGP 12177 |
25 |
| beta-Carbonic Anhydrase |
Carbon Dioxide |
37 |
| beta-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ) |
crotonoyl-CoA |
53 |
| beta-Ketoacyl-ACP Synthase III (FabH) |
Malonyl-ACP |
58 |
| beta-Secretase (BACE-1) |
APP_NFEV |
23 |
| BACE Peptide Substrate |
62 |
| BACE Substrate Peptide |
85 |
| BACE-1 Peptide Substrate |
16 |
| BACE-1 Substrate Peptide |
47 |
| ELGY-9 |
7 |
| Fluorescent Substrate |
110 |
| fluorescent substrate FS-2 |
7 |
| Fluorogenic Substrate |
37 |
| FS1 FRET Substrate |
4 |
| MBPAPPC125 |
30 |
| beta-Secretase (BACE-2) |
BACE Peptide Substrate |
5 |
| BACE Substrate Peptide |
7 |
| Fluorescent Substrate |
100 |
| Fluorogenic Substrate |
12 |
| Bfl-1 |
F-Bim |
198 |
| FITC-conjugated-Bim BH3 Peptide |
8 |
| Bfl-1 |
FITC-Ahx-EDIIRNIARHLAQVGDSMDR |
44 |
| Biotin Carboxylase |
Biotinyl-BCCP |
14 |
| Bone Morphogenetic Protein Receptor type II (BMPR2) |
biotinylated affinity ligand |
6 |
| Botulinum Neurotoxin Type A |
SNAP-25 substrate peptide |
18 |
| SNAP-25-based peptide substrate |
16 |
| SNAPtide |
99 |
| Butyrylcholinesterase (BuChE) |
butyrylthiocholine |
603 |
| butyrylthiocholine chloride |
28 |
| C-Raf Protein Kinase |
MEK Inactive Mutant |
34 |
| Calcium-Sensing Receptor (CaSR) |
Not Available |
44 |
| Calpain-1 |
BODIPY FL casein |
10 |
| Suc-Leu-Tyr-AMC |
11 |
| Calpain-2 |
BODIPY FL casein |
10 |
| CaM Kinase II |
Autocamtide-2 |
38 |
| CaM Kinase II Peptide Substrate |
4 |
| cAMP-Dependent Protein Kinase (PKA) |
biotinylated kemptide |
30 |
| Fluorescent probe ARC-583 |
27 |
| histone (type H IIas) |
15 |
| histone (type Vs) |
61 |
| Histone H1 |
10 |
| Histone type HL |
67 |
| Histone VII-S |
13 |
| ING Peptide |
16 |
| Kemptide |
81 |
| Lys-rich histone |
97 |
| Peptide Substrate |
11 |
| PKA Peptide Substrate |
5 |
| PKA-specific peptide substrate |
21 |
| stathmin |
1 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (1) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (2) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (3) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (4) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR2 (1) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR2 (2) |
Kemptide |
1 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR2 (3) |
Kemptide |
3 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR3 |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR3 (1) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR4 |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR5 |
Kemptide |
5 |
| Cannabinoid Receptor 1 |
GTP-gamma-S |
19 |
| [3H]CP55940 |
109 |
| [3H]SR141716A |
44 |
| Cannabinoid Receptor 2 |
[3H]CP55940 |
122 |
| [3H]SR141716A |
10 |
| Carbonic Anhydrase (hpCA) |
Carbon Dioxide |
47 |
| Carbonic Anhydrase (mtCA 1) |
Carbon Dioxide |
37 |
| Carbonic Anhydrase (mtCA 3) |
Carbon Dioxide |
37 |
| Carbonic Anhydrase 2 (Can2) |
Carbon Dioxide |
37 |
| Carbonic Anhydrase I |
4-nitrophenyl acetate |
139 |
| Carbon Dioxide |
315 |
| dansylamide |
5 |
| Carbonic Anhydrase II |
4-nitrophenyl acetate |
173 |
| Carbon Dioxide |
401 |
| dansylamide |
52 |
| Carbonic Anhydrase II Mutant (F131V) |
dansylamide |
11 |
| Carbonic Anhydrase III |
Carbon Dioxide |
49 |
| Carbonic Anhydrase IV |
4-nitrophenyl acetate |
133 |
| Carbon Dioxide |
134 |
| Carbonic Anhydrase IX |
Carbon Dioxide |
265 |
| Carbonic Anhydrase VA |
Carbon Dioxide |
149 |
| Carbonic Anhydrase VB |
Carbon Dioxide |
103 |
| Carbonic Anhydrase VI |
Carbon Dioxide |
85 |
| Carbonic Anhydrase VII |
Carbon Dioxide |
52 |
| Carbonic Anhydrase XII |
Carbon Dioxide |
69 |
| Carbonic Anhydrase XIII |
Carbon Dioxide |
51 |
| Carbonic Anhydrase XIV |
Carbon Dioxide |
53 |
| Carbonic Anhydrase XV |
Carbon Dioxide |
73 |
| Carboxylesterase 1 |
Nitrophenyl Acetate |
271 |
| Carboxylesterase 2 (intestine, liver) |
Nitrophenyl Acetate |
146 |
| Carboxypeptidase A (CPA) |
Furylacryloyl-Phe-Phe |
15 |
| Casein Kinase I |
Casein |
8 |
| CK1 Peptide Substrate |
4 |
| CK1 Substrate Peptide |
1 |
| Casein Kinase II |
CK-2 Peptide Substrate |
15 |
| CK2 Peptide Substrate |
1 |
| Peptide Substrate |
25 |
| stathmin |
1 |
| Caspase-1 |
Caspase-1 Fluorogenic Substrate |
115 |
| Caspase-1 Fluorogenic Substrate Ac-Trp-Glu-His-Asp-AFC |
9 |
| Caspase-1 Substrate |
20 |
| Fluorometric Tetrapeptide Ac-DEVD-AMC |
1 |
| Caspase-2 |
Caspase Substrate |
7 |
| Caspase-2 Fluorogenic Substrate |
8 |
| Caspase-2 Fluorogenic Substrate Ac-Val-Asp-Val-Ala-Asp-AFC |
9 |
| Caspase-3 |
Ac-DEVD-AFC |
42 |
| Caspase Fluorogenic Substrate |
188 |
| Caspase-3 (7) Fluorogenic Substrate |
11 |
| Caspase-3 Fluorogenic Substrate |
35 |
| Caspase-3 Fluorogenic Substrate Ac-Asp-Glu-Val-Asp-AFC |
49 |
| Caspase-3 Substrate |
73 |
| Fluorometric Tetrapeptide Ac-DEVD-AMC |
1 |
| Caspase-4 |
Caspase-4 Fluorogenic Substrate |
8 |
| Caspase-4 Fluorometric Substrate Ac-Trp-Glu-His-Asp-AFC |
9 |
| Caspase-5 |
Caspase-5 Fluorometric Substrate Ac-Trp-Glu-His-Asp-AFC |
9 |
| Caspase-6 |
Caspase Fluorogenic Substrate |
8 |
| Caspase Substrate |
7 |
| Caspase-6 Fluorogenic Substrate |
29 |
| Caspase-6 Fluorometric Substrate Ac-Val-Glu-Ile-Asp-AFC |
9 |
| Caspase-6 Substrate |
22 |
| Caspase-7 |
Caspase Fluorogenic Substrate |
85 |
| Caspase Substrate |
7 |
| Caspase-3 (7) Fluorogenic Substrate |
11 |
| Caspase-7 Fluorometric Substrate Ac-Asp-Glu-Val-Asp-AFC |
9 |
| Caspase-7 Substrate |
20 |
| Caspase-8 |
Caspase Substrate |
7 |
| Caspase-8 Fluorogenic Substrate |
96 |
| Caspase-8 Fluorometric Substrate Ac-Ile-Glu-Thr-Asp-AFC |
9 |
| Caspase-8 Substrate |
20 |
| Caspase-9 |
Caspase-9 Fluorogenic Substrate |
8 |
| Cathepsin B |
Boc-Leu-Lys-Arg-AMC |
100 |
| Cbz-Phe-Arg-AMC |
36 |
| Z-Arg-Arg-AMC |
24 |
| Z-Phe-Arg-NMec |
13 |
| Cathepsin B |
Z-Arg-Arg-AMC |
56 |
| Cathepsin B-Like Cysteine Protease (TbcatB) |
Z-Phe-Arg-AMC |
56 |
| Cathepsin D |
Cathepsin D FRET Substrate |
1 |
| Cathepsin D Peptide Substrate |
57 |
| Cathepsin D/Pepsin Peptide Substrate |
5 |
| Fluorescent Substrate |
100 |
| MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 |
27 |
| Peptide Substrate |
104 |
| Cathepsin K |
Ac-Lys-His-Pro-Lys-ACMC |
170 |
| Cbz-Leu-Arg-AMC |
173 |
| Cbz-Phe-Arg-AMC |
114 |
| Z-Leu-Arg-NHMec |
48 |
| Z-Phe-Arg-AMC |
24 |
| Cathepsin L |
Ac-His-Lys-Phe-Lys-ACMC |
170 |
| Cbz-Leu-Arg-AMC |
100 |
| Cbz-Phe-Arg-AMC |
87 |
| Cbz-Phe-Arg-MCA |
13 |
| Z-Phe-Arg-AMC |
24 |
| Z-Phe-Arg-NHMec |
52 |
| Cathepsin L2 |
Z-Phe-Arg-AMC |
24 |
| Cathepsin S |
Ac-His-Pro-Val-Lys-ACMC |
180 |
| Cathepsin S Substrate Peptide |
28 |
| Cbz-Leu-Arg-AMC |
8 |
| Cbz-Phe-Arg-AMC |
9 |
| Z-Leu-Leu-Arg-AMC |
43 |
| Z-Phe-Arg-AMC |
24 |
| Z-Val-Val-Arg-AMC |
130 |
| Z-Val-Val-Arg-NHMec |
48 |
| Cathepsin V |
Cbz-Phe-Arg-AMC |
2 |
| Cdc7 Kinase |
His6-tagged MCM2 |
16 |
| MCM2 |
85 |
| Cell Division Cycle 2-Like 1(CDC2L1) |
biotinylated affinity ligand |
7 |
| Cell Division Cycle 2-Like 2 (CDC2L2) |
biotinylated affinity ligand |
7 |
| Cell Division Cycle 2-Like 6 (CDK11) |
biotinylated affinity ligand |
11 |
| cGMP-Dependent Protein Kinase |
Histone H1 |
10 |
| Histone II-A |
13 |
| Checkpoint Kinase (Chk1) |
biotinylated CDC25C peptide |
13 |
| biotinylated cdc25c peptide substrate |
2 |
| biotinylated CHKtide |
9 |
| Biotinylated Peptide Substrate |
24 |
| Cdc25C peptide substrate |
124 |
| Chktide |
31 |
| Not Available |
1 |
| Synthetic Chk1 Peptide Substrate |
3 |
| Checkpoint Kinase (Chk2) |
biotinylated CDC25C peptide |
4 |
| Fam-CHK2tide |
7 |
| Histone H1 |
4 |
| Chitinase |
fluorogenic substrate |
12 |
| Not Available |
3 |
| Chitinase Mutant (A217G) |
Not Available |
3 |
| Chitinase Mutant (D175A) |
Not Available |
3 |
| Chitinase Mutant (D246A) |
Not Available |
1 |
| Chitinase Mutant (E177A) |
Not Available |
1 |
| Chitinase Mutant (E322A) |
Not Available |
3 |
| Chitinase Mutant (M243A) |
Not Available |
3 |
| Chitinase Mutant (R301K) |
Not Available |
3 |
| Chitinase Mutant (T138A) |
Not Available |
3 |
| Chitinase Mutant (Y245F) |
Not Available |
2 |
| Cholecystokinin-1 Receptor |
[125I]CCK-8 |
17 |
| Cholecystokinin-2 Receptor |
[125I]CCK-8 |
17 |
| Chymase |
Chymase/Chymotrypsin Chromogenic Substrate |
2 |
| Chymotrypsin |
Chymase/Chymotrypsin Chromogenic Substrate |
2 |
| Suc-Ala-Ala-Pro-Phe-7-amino-4-methylcoumarin |
27 |
| cIAP-1 BIR3 |
AVP-diPhe-FAM |
5 |
| Smac-derived peptide |
5 |
| cIAP-2 BIR3 |
AVP-diPhe-FAM |
5 |
| Smac-derived peptide |
5 |
| cIAP1-BIR3 |
AVP-diPhe-FAM |
5 |
| cIAP2-BIR3 |
AVP-diPhe-FAM |
3 |
| CLK1 |
biotinylated affinity ligand |
16 |
| CLK4 |
biotinylated affinity ligand |
13 |
| Collagenase (ChC) |
Collagenase Substrate |
187 |
| Corticotropin-releasing Factor Receptor 1 |
125I-Tyr(0)-ovine-CRF |
135 |
| Cyclin-Dependent Kinase 1 (CDK1) |
biotinylated CDK peptide substrate |
3 |
| Biotinylated CDK1 Peptide Substrate |
99 |
| Biotinylated peptide substrate |
4 |
| GST-Rb fusion protein |
85 |
| Histidine-tagged retinoblastoma protein |
26 |
| Histone H1 |
652 |
| Not Available |
1 |
| Peptide Substrate |
102 |
| Rb (Ser780) Biotinylated Peptide |
4 |
| S1 peptide |
5 |
| Substrate Peptide SerThr 18 |
3 |
| Cyclin-Dependent Kinase 2 (CDK2) |
biotinylated CDK peptide substrate |
3 |
| Biotinylated peptide substrate |
91 |
| CDK2 biotinylated peptide substrate |
4 |
| CDK2 Peptide Subsrate |
22 |
| CDKtide |
3 |
| GST-Rb fusion protein |
675 |
| Histidine-tagged Rb |
68 |
| Histidine-tagged retinoblastoma protein |
26 |
| Histone H1 |
548 |
| Histone type 3 |
20 |
| ING Peptide |
144 |
| Not Available |
1 |
| Peptide Substrate |
132 |
| Rb(21) |
8 |
| S1 peptide |
13 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (F82H) |
Histone H1 |
1 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (F82H/L83V/H84D) |
Histone H1 |
2 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (F82H/L83V/H84D/K89T) |
Histone H1 |
2 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (K89T) |
Histone H1 |
2 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (L83V/H84D) |
Histone H1 |
1 |
| Cyclin-Dependent Kinase 4 (CDK4) |
Biotinylated Peptide Substrate |
30 |
| G1 peptide |
43 |
| GST-Rb fusion protein |
665 |
| Histidine-tagged retinoblastoma protein |
26 |
| Histone H1 |
9 |
| ING Peptide |
160 |
| Rb |
2 |
| Rb(21) |
95 |
| Retinoblastoma (Rb) |
13 |
| Cyclin-Dependent Kinase 5 (CDK5) |
Cdk5 Substrate |
1 |
| Histone H1 |
301 |
| Histone H1 Peptide |
1 |
| Cyclin-Dependent Kinase 6 (CDK6) |
G1 peptide |
1 |
| Histone H1 |
7 |
| Cyclin-Dependent Kinase 7 (CDK7) |
biotinylated affinity ligand |
12 |
| Biotinylated Peptide Substrate |
7 |
| FAM-CDK7 derived peptide |
18 |
| Histone H1 |
4 |
| Cyclin-Dependent Kinase 8 (CDK8) |
biotinylated affinity ligand |
8 |
| Cyclin-Dependent Kinase 9 (CDK9) |
biotinylated affinity ligand |
6 |
| Biotinylated Peptide Substrate |
7 |
| pRB |
4 |
| RNA Polymerase CTD Peptide |
2 |
| Cyclooxygenase-1 |
Arachidonic acid |
33 |
| [1-14C]Arachidonic acid |
39 |
| Cyclooxygenase-2 |
Arachidonic acid |
30 |
| [1-14C]Arachidonic acid |
45 |
| Cytochrome P450 1A2 |
Ethoxyresorufin |
1 |
| Cytochrome P450 2A6 |
Coumarin |
31 |
| Cytochrome P450 2C19 |
3-butyryl-7- methoxycoumarin |
7 |
| S-Mephenytoin |
1 |
| Cytochrome P450 2C9 |
7-methoxy-4-trifluoromethylcoumarin-3-acetic acid |
7 |
| Diclofenac |
1 |
| MFC |
21 |
| Cytochrome P450 2D6 |
4-Methylaminomethyl-7-methoxycoumarin |
7 |
| Bufuralol |
1 |
| Cytochrome P450 2E1 |
p-nitrophenol |
9 |
| Cytochrome P450 3A1 |
erythromycin |
11 |
| Cytochrome P450 3A4 |
7-Benzyloxyquinoline |
7 |
| BFC |
31 |
| Midazolam |
1 |
| Testosterone |
52 |
| Cytochrome P450 51(CYP51) |
Not Available |
26 |
| Cytochrome P450 51(CYP51) Mutant (F78L) |
Not Available |
2 |
| D-Amino Acid Oxidase (DAAO) |
D-Serine |
61 |
| Not Available |
7 |
| D-Aspartate Oxidase (DDO) |
D-Aspartic Acid |
23 |
| Delta Opioid Receptor |
[3H]-diprenorphine |
69 |
| [3H]-naltrindole |
21 |
| [3H]DPDPE |
53 |
| Dengue Virus 1 (DENV1) NS2B-NS3 Protease |
Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Dengue Virus 2 (DENV2) NS2B-NS3 Protease |
Boc-Gly-Arg-Arg-AMC |
5 |
| Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Dengue Virus 3 (DENV3) NS2B-NS3 Protease |
Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Dengue Virus 4 (DENV4) NS2B-NS3 Protease |
Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Diacyl Glycerolacyltransferase 1 (DGAT-1) |
didecanoyl glycerol |
25 |
| [14C] oleoyl coenzyme A |
9 |
| Diacyl Glycerolacyltransferase 2 (DGAT-2) |
[14C] oleoyl coenzyme A |
2 |
| Dihydrofolate Reductase (DHFR) |
dihydrofolic acid |
612 |
| Dihydrofolate Reductase (DHFR) Mutant (F98Y) |
dihydrofolic acid |
2 |
| Dihydrofolate Reductase (DHFR) Mutant (I100L) |
dihydrofolic acid |
2 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) |
dihydrofolic acid |
22 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant KICB1 |
dihydrofolic acid |
3 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant SP21 |
dihydrofolic acid |
19 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant V1/S |
dihydrofolic acid |
3 |
| Dihydroorotate Dehydrogenase (DHODH) |
Coenzyme Q1 |
9 |
| Coenzyme Q6 |
18 |
| Decylubiquinone |
181 |
| Ubiquinone-0 (CoQ0) |
40 |
| Dihydroorotate Dehydrogenase (DHODH) Mutant (H185A) |
Ubiquinone-0 (CoQ0) |
13 |
| Dihydroorotate Dehydrogenase (DHODH) Mutant (R265A) |
Ubiquinone-0 (CoQ0) |
13 |
| Dipeptidyl Peptidase II (DPP-II) (QPP) |
Nle-Pro-AMC |
52 |
| Dipeptidyl Peptidase IV (DPP-IV) |
Ala-Pro-7-amido-4-trifluoromethylcoumarin |
48 |
| Gly-Pro-AMC |
501 |
| Gly-Pro-pNA |
149 |
| H-Ala-Pro-pNA |
49 |
| Dipeptidyl Peptidase VII (DPP-VII) (QPP) |
Gly-Pro-pNA |
47 |
| Lys-Ala-pNA |
67 |
| Nle-Pro-AMC |
215 |
| DNA Gyrase |
ATP |
44 |
| Kinetoplast DNA |
5 |
| DNA Ligase (MtuLigA) |
32P-labeled nicked duplex DNA substrate |
7 |
| DNA Ligase I |
32P-labeled nicked duplex DNA substrate |
4 |
| DNA Polymerase alpha |
dGTP |
2 |
| DNA template-primer |
10 |
| DNA Polymerase beta |
DNA template-primer |
10 |
| DNA Polymerase gamma |
dGTP |
2 |
| DNA polymerase IIIC |
dGTP |
2 |
| DNA polymerase IIIE |
dGTP |
4 |
| DNA Topoisomerase IV |
ATP |
22 |
| Kinetoplast DNA |
5 |
| Dopamine Receptor D2 |
[3H]-Spiroperidol |
39 |
| Dopamine Transporter (DAT) |
[125I]RTI-55 |
64 |
| [3H]WIN 35,428 |
19 |
| DPP8 |
Ala-Pro-7-amido-4-trifluoromethylcoumarin |
297 |
| Gly-Pro-AMC |
38 |
| Gly-Pro-pNA |
65 |
| DPP9 |
Gly-Pro-AMC |
275 |
| Dual Specificity Protein Phosphatase 1 |
OMFP Substrate |
165 |
| DYRK1A |
myelin basic protein |
3 |
| EGF-R Tyrosine Kinase |
(Biotin)Poly(Glu:Tyr) |
4 |
| Angiotensin II |
30 |
| Biotinylated EGFR Peptide Substrate |
19 |
| biotinylated gastrin substrate |
1 |
| Biotinylated Peptide Substrate |
41 |
| EGF Receptor Substrate |
23 |
| EGF-R Substrate |
325 |
| EGFR Substrate |
174 |
| EGFR Substrate Peptide |
22 |
| N-biotinyl peptide substrate |
1 |
| Not Available |
19 |
| poly(E, A, Y) |
93 |
| poly(E,A,Y) |
30 |
| poly(E,Y) |
13 |
| Poly(E:A:Y) |
3 |
| Poly(E:Y) |
131 |
| Poly(GAT) |
170 |
| poly(Glu4-Tyr) |
13 |
| poly(Glu4/Tyr) |
24 |
| Tyr 04 Substrate Peptide |
4 |
| EGF-R Tyrosine Kinase Mutant (G719C) |
biotinylated affinity ligand |
20 |
| EGF-R Tyrosine Kinase Mutant (G719S) |
Not Available |
2 |
| EGF-R Tyrosine Kinase Mutant (L858R) |
Not Available |
4 |
| EGF-R Tyrosine Kinase Mutant (L858R/T790M) |
Not Available |
2 |
| EGF-R Tyrosine Kinase Mutant (T790M) |
Not Available |
2 |
| Tyr 04 Substrate Peptide |
4 |
| Endothelin-Converting Enzyme 1 |
Pya(21)-(p-NO2)Phe(22)bigET(19-35) |
29 |
| Enoyl-ACP Reductase (FabI) |
Crotonoyl-ACP |
50 |
| Crotonoyl-CoA |
111 |
| Enoyl-ACP Reductase (FabK) |
Crotonoyl-ACP |
5 |
| Enoyl-ACP Reductase (InhA) |
2-trans-Octenoyl-CoA (OCoA) |
100 |
| trans-2-Dodecenoyl-Coenzyme A |
13 |
| Enoyl-ACP Reductase (PfENR) |
Crotonoyl-CoA |
28 |
| Epoxide Hydrolase B (EHB) |
alpha-cyanocarbonate epoxide |
20 |
| Equilibrative Nucleoside Transporter 1 (ENT1) |
5-(SAENTA)-X8-fluorescein |
80 |
| ErbB-2 (HER2) Tyrosine Kinase |
Biotinylated ErbB-2 Peptide Substrate |
19 |
| Biotinylated Peptide Substrate |
41 |
| ErbB-2 Substrate Peptide |
22 |
| HER-2 Substrate |
38 |
| poly(Glu4/Tyr) |
24 |
| ErbB-4 (HER4) Tyrosine Kinase |
Biotinylated ErbB-4 Peptide Substrate |
9 |
| ERK-2 |
biotin-MBP protein |
1 |
| EGFR Peptide Substrate |
2 |
| ERK-2 Peptide Substrate |
4 |
| ERKtide |
57 |
| Histone H1 |
3 |
| Substrate Peptide T669 |
5 |
| ERK-8 |
biotinylated affinity ligand |
9 |
| Estrogen Receptor (ER-alpha) |
17beta-estradiol (E2) |
134 |
| Estrone (E1) |
56 |
| [3H]-estradiol |
25 |
| [3H]]estradiol |
15 |
| Estrogen Receptor (ER-beta) |
17beta-estradiol (E2) |
134 |
| Estrone (E1) |
56 |
| Estrogen-Related Receptor, alpha |
PGC-1 alpha derived peptide |
2 |
| Estrogen-Related Receptor, gamma |
Biotinylated RIP140 peptide |
12 |
| [3H]4-OHT |
19 |
| Factor IXa (fIXa) |
Chromogenic Substrate |
7 |
| Factor IX Chromogenic Substrate |
85 |
| Factor VIIa (fVIIa) |
Chromogenic Substrate |
7 |
| Chromozym tPA |
66 |
| Factor VII Chromogenic Substrate |
108 |
| Not Specified |
3 |
| Pefachrome FVIIa |
96 |
| Spectrozyme-FVIIa |
46 |
| Factor Xa (fXa) |
Chromogenic Substrate Pefachrome FXa |
63 |
| Chromogenic Substrate S-2222 |
461 |
| Chromogenic Substrate S-2765 |
472 |
| Chromogenic Substrate Spectrozyme FXa |
37 |
| Chromozym X |
39 |
| Factor Xa (fXa) Chromogenic Substrate |
57 |
| Factor Xa Chromogenic Substrate |
7 |
| Factor Xa Fluorogenic Substrate |
24 |
| MeSO2-D-Nle-Gly-Arg-pNA |
54 |
| Not Specified |
3 |
| rhodamime 110, bis-(Boc-L-glycylglycyl-L-arginine amide) |
25 |
| Factor XIa (fXIa) |
Boc-Glu-Ala-Arg-AMC |
396 |
| Fluorogenic Tripeptide Substrate |
31 |
| Not Specified |
3 |
| Factor XIIa (fXIIa) |
Boc-Gln-Gly-Arg-AMC |
87 |
| Chromogenic Substrate S-2302 |
36 |
| Falcipain-2 |
Z-Leu-Arg-AMC |
30 |
| Farnesoid X-Activated Receptor |
biotin-tagged SRC-1 |
4 |
| Biotinylated SRC-1 Peptide |
5 |
| Not Available |
54 |
| Fatty Acid Amide Hydrolase |
14C-labeled oleamide |
115 |
| FP-rhodamine |
1 |
| Oleamide |
16 |
| [14C]Anandamide |
39 |
| [3H]Anandamide |
82 |
| Fatty Acid Synthase |
4-methylumbelliferyl heptanoate (4-MUH) |
46 |
| FGFR-1 Tyrosine Kinase |
Biotinylated FGFR Peptide Substrate |
2 |
| biotinylated gastrin substrate |
1 |
| N-biotinyl peptide substrate |
1 |
| Poly (E:Y) |
1 |
| poly(E,A,Y) |
67 |
| Poly(E:Y) |
486 |
| Substrate Peptide Tyr 04 |
1 |
| FGFR-2 Tyrosine Kinase |
(Biotin)Poly(Glu:Tyr) |
3 |
| FGFR Substrate |
7 |
| Fibroblast Activation Protein (FAP) |
Gly-Pro-pNA |
18 |
| Formyl Peptide Receptor-Like 1 |
Not Available |
18 |
| G-protein Coupled Receptor 40 |
Not Available |
52 |
| G-protein Coupled Receptor 54 |
[125I]Kisspeptin-15 |
12 |
| GABAA Receptor Mutant, alpha-1 (A160C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (D97C), beta-2, gamma-2 |
[3H]Ro15-1788 |
1 |
| GABAA Receptor Mutant, alpha-1 (F99C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (G157C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (G200C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (S204C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (S205C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (T162C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (T206C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (V202C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (V211C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (Y209C), beta-2, gamma-2 |
[3H]Ro15-1788 |
1 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (A79C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (Chimera) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (D56C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (F77C) |
[3H]Ro15-1788 |
1 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (L140C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (M130C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R132C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R144C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R185C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R194C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (T126C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (T142C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (T81C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-1, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-1, beta-3, gamma-2 |
[3H]flunitrazepam |
8 |
| GABAA Receptor, alpha-2, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-2, beta-3, gamma-2 |
[3H]flunitrazepam |
8 |
| GABAA Receptor, alpha-3, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-3, beta-3, gamma-2 |
[3H]flunitrazepam |
7 |
| GABAA Receptor, alpha-4, beta-2, gamma-2 |
[3H]Ro15-4513 |
3 |
| GABAA Receptor, alpha-4, beta-3, gamma-2 |
[3H]flunitrazepam |
4 |
| GABAA Receptor, alpha-5, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-5, beta-3, gamma-2 |
[3H]flunitrazepam |
8 |
| GABAA Receptor, alpha-6, beta-2, gamma-2 |
[3H]Ro15-4513 |
3 |
| GABAA Receptor, alpha-6, beta-3, gamma-2 |
[3H]flunitrazepam |
7 |
| Galectin-1 |
fluorescein-tagged saccharide |
14 |
| Galectin-3 |
fluorescein-tagged saccharide |
23 |
| Galectin-7 |
fluorescein-tagged saccharide |
12 |
| Galectin-8 |
fluorescein-tagged saccharide |
11 |
| Galectin-9 |
fluorescein-tagged saccharide |
12 |
| gamma-Aminobutyric Acid Type B Receptor |
[3H]GABA |
16 |
| Gamma-Secretase |
beta-Amyloid Precursor Protein (APP) |
98 |
| GAR Tfase |
GAR |
18 |
| Gastric Inhibitory Polypeptide Receptor (GIPR) |
125I-GIP |
30 |
| Geranylgeranyl Diphosphate Synthase (GGPPS) |
[14C]IPP |
61 |
| Geranylgeranyl Transferase (GGTase-I) |
Biotinylated Peptide Substrate |
29 |
| Ha-Ras-CVLL |
28 |
| K-ras(B) decapeptide |
43 |
| PGGT I peptide substrate |
1 |
| Ras-CVLL |
1 |
| Ghrelin Receptor (Growth Hormone Secretagogue Receptor Type 1) |
125I-His9-ghrelin |
118 |
| Not Available |
13 |
| Glucagon Receptor |
125I-Glucagon |
30 |
| Glucocerebrosidase (Acid beta-Glucosidase) |
4-methylumbelliferyl beta-D-glucoside |
18 |
| resorufin-beta-D-glucopyranoside |
59 |
| Glucocorticoid Receptor (GR) |
dexamethasone |
84 |
| dexamethasone (tetramethyl-rhodamine conjugated ) |
49 |
| Glucokinase |
D-glucose |
34 |
| Glutamate Carboxypeptidase II (GCPII) |
N-acetylaspartylglutamate (NAAG) |
42 |
| Glutaminyl Cyclase |
Gln-AMC |
90 |
| Glycogen Phosphorylase (PYGL) |
glycogen |
102 |
| Glycogen Phosphorylase (PYGM) |
glucose-1-phosphate |
73 |
| Glycogen Synthase Kinase-3, alpha |
Biotinylated Peptide Substrate |
171 |
| GSK-3 Peptide Substrate |
2 |
| Glycogen Synthase Kinase-3, beta |
Biotinylated Peptide Substrate |
182 |
| GS-1 peptide |
344 |
| GSK-3 beta Substrate Peptide |
30 |
| GSK-3 Peptide Substrate |
29 |
| GSK-3 Substrate Peptide |
24 |
| Phospho-GS2 Substrate Peptide |
1 |
| Phosphor-Glycogen Synthase Peptide-2 |
3 |
| GRB2 |
Grb2 SH2 Binding Substrate |
15 |
| HCV NS3 Helicase |
DNA Substrate |
12 |
| HCV NS3-NS4A Serine Proteinase |
NS3-NS4A Chromogenic Peptide Substrate |
291 |
| NS4B-5A |
30 |
| HCV NS5B Polymerase |
biotinylated oligo (rG13)/poly rC |
165 |
| poly(A)/oligo(U)18 |
43 |
| HCV NS5B Polymerase Mutant (M414T) |
poly(A)/oligo(U)18 |
2 |
| HCV NS5B Polymerase Mutant (M423K) |
poly(A)/oligo(U)18 |
2 |
| HCV NS5B Polymerase Mutant (P495A) |
poly(A)/oligo(U)18 |
2 |
| HCV NS5B Polymerase Mutant (R501E) |
poly(A)/oligo(U)18 |
2 |
| Heat Shock 70kDa Protein 1 |
Fluorescein-12-ATP |
33 |
| N6-(6-amino)hexyl-ATP-5-FAM |
17 |
| Not Available |
8 |
| Heat Shock Protein 90 (Hsp90) |
ATP |
14 |
| BODIPY-labeled Geldanamycin |
9 |
| cy3B-GM |
268 |
| Not Available |
81 |
| VER-00045864 |
25 |
| VER-00051001 |
100 |
| Heme Oxygenase 1 (HO-1) |
methemalbumin |
44 |
| Heme Oxygenase 2 (HO-2) |
methemalbumin |
44 |
| Hepsin |
Hepsin Chromogenic Substrate |
6 |
| hERG Potassium Channel 1 |
Not Available |
10 |
| [35S]-MK499 |
53 |
| [3H]Astemizole |
21 |
| Histamine H1 Receptor |
[3H]Chlorpheniramine |
18 |
| [3H]mepyramine |
5 |
| [3H]pyrilamine |
3 |
| Histamine H2 Receptor |
tiotidine |
1 |
| [3H]tiotidine |
5 |
| Histamine H3 Receptor |
[3H]N-alpha-methyl histamine |
104 |
| Histamine H4 Receptor |
[3H]histamine |
119 |
| Histone Deacetylase (pfHDAC-1) |
pfHDAC-1 Substrate |
23 |
| Histone Deacetylase 1 (HDAC1) |
Ac-KGLGK(Ac)-AMC |
14 |
| acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
5 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
18 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor de Lys-H4-AcK16 |
25 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
100 |
| Fluorophore-conjugated substrate |
3 |
| [3H]acetyl-labeled histones |
19 |
| Histone Deacetylase 10 (HDAC10) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
17 |
| Histone Deacetylase 11 (HDAC11) |
Boc-Ac-Lys-AMC |
1 |
| Histone Deacetylase 2 (HDAC2) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
18 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
5 |
| Histone Deacetylase 3 (HDAC3) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
7 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
17 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
62 |
| Histone Deacetylase 4 (HDAC4) |
Ac-KGLGK(Ac)-AMC |
8 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-L-Lys-MCA |
48 |
| [3H]acetyl-labeled histones |
19 |
| Histone Deacetylase 4 (HDAC4) Mutant (H976Y) |
Fluor-de-Lys Fluorogenic Deacetylase Substrate |
48 |
| Histone Deacetylase 5 (HDAC5) |
Boc-Ac-Lys-AMC |
1 |
| Boc-L-Lys-MCA |
5 |
| Histone Deacetylase 6 (HDAC6) |
Ac-KGLGK(Ac)-AMC |
14 |
| acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
47 |
| Fluorophore-conjugated substrate |
3 |
| [3H]acetyl-labeled histones |
19 |
| Histone Deacetylase 7 (HDAC7) |
Boc-Ac-Lys-AMC |
1 |
| Boc-L-Lys-MCA |
5 |
| Histone Deacetylase 8 (HDAC8) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
7 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor de Lys-HDAC8 Fluorogenic Deacetylase Substrate |
22 |
| Fluorophore-conjugated substrate |
3 |
| Histone Lysine Demethylase |
Histone H3 fragment substrate |
19 |
| Histone-Arginine Methyltransferase CARM1 |
Histone H3 |
19 |
| HIV-1 Integrase |
Biotinylated Target DNA |
144 |
| DIG-tagged Target DNA |
13 |
| [3H]Target DNA |
88 |
| HIV-1 Protease |
Biotinylated HIV-1 Protease Peptide Substrate |
84 |
| Chromogenic peptide substrate |
5 |
| Chromogenic peptide substrate |
74 |
| Chromogenic Substrate |
3 |
| decapeptide substrate |
46 |
| fluorescence peptide substrate |
1 |
| Fluorescent peptide substrate |
408 |
| Fluorogenic Peptide Substrate |
324 |
| fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| Fluorogenic substrate |
13 |
| Fluorogenic substrate Abz-NF-6* |
11 |
| HIV Peptide Substrate |
2 |
| HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV Protease peptide substrate |
304 |
| HIV Protease substrate |
268 |
| HIV-1 Peptide Substrate |
83 |
| HIV-1 PR Substrate Peptide |
11 |
| HIV-1 Protease substrate |
111 |
| HIV-1 proteinase peptide substrate |
18 |
| Peptide substrate |
721 |
| [3H]GW0385 |
16 |
| HIV-1 Protease AE |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease AE Mutant (V82F) |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease AE-P |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease AE-P Mutant (F82V) |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease B Subtype |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease B Subtype Mutant (V82F) |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease Mutant (A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (A71V/V82T/I84V) |
Chromogenic peptide substrate |
1 |
| HIV-1 Protease Mutant (D30N) |
Chromogenic peptide substrate |
5 |
| HIV Peptide Substrate |
2 |
| HIV-1 Protease Mutant (D30N/A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (D30N/M36I) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (D30N/M36I/A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (G73S) |
Chromogenic Substrate |
3 |
| HIV-1 Protease Mutant (I47L) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (I50L) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (I50V) |
Chromogenic Substrate |
3 |
| fluorescence peptide substrate |
1 |
| HIV Peptide Substrate |
2 |
| [3H]GW0385 |
5 |
| HIV-1 Protease Mutant (I84V) |
HIV Peptide Substrate |
2 |
| HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L10I,L19Q,K20R,E35D,M36I, ..) |
fluorescence peptide substrate |
1 |
| [3H]GW0385 |
5 |
| HIV-1 Protease Mutant (L23I) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L23V) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L24I) |
Chromogenic Substrate |
3 |
| HIV-1 Protease Mutant (L76M) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L90M) |
HIV Peptide Substrate |
2 |
| HIV-1 Protease Mutant (M36I) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (M36I/A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (M46I,L63P,A71V,V82F,I84V) |
fluorescence peptide substrate |
1 |
| [3H]GW0385 |
5 |
| HIV-1 Protease Mutant (V32I) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (V82A) |
HIV Peptide Substrate |
2 |
| HIV Protease Chromogenic Peptide Substrate |
3 |
| HIV-1 Protease Mutant (V82I) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant K-60C |
HIV Protease Peptide Substrate |
15 |
| HIV-1 Protease Mutant M1 (L10I, G48V, I54V, L63P, V82A) |
HIV-1 Protease Substrate |
19 |
| HIV-1 Protease Mutant M2 (D30N, L63P, N88D) |
HIV-1 Protease Substrate |
19 |
| HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) |
HIV-1 Protease Substrate |
19 |
| HIV-1 Protease Mutant Q-60C |
HIV Protease Peptide Substrate |
11 |
| HIV-1 Protease Mutant V-18C |
HIV Protease Peptide Substrate |
27 |
| HIV-1 Protease Mutant V6 |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(46) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(46/54/84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(46/84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(54) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(54/84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant, A-1 |
fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| HIV-1 Protease Mutant, ANAM-11 |
fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| HIV-1 Protease Mutant, NAM-10 |
fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| HIV-1 Reverse Transcriptase |
(poly)rA:(oligo)dT(12-18) |
139 |
| (poly)rC:(oligo)dG |
224 |
| (rC)n.(dG)12-18 |
149 |
| poly r(A).oligo d(T)16 |
10 |
| poly rC/biotin-dG15 |
36 |
| poly(A)/oligo(dT) |
26 |
| Poly(C)-oligo(dG) |
7 |
| poly(rA)-oligo(dT) |
5 |
| poly(rA)-oligo(dT)(12-18) |
11 |
| poly(rA).oligo(dT)12-18 |
28 |
| poly(rA)/oligo(dT) |
14 |
| poly(rA)600:oligo(dT)10 |
45 |
| poly(rA):oligo(dT) template:primer |
11 |
| poly(rA):oligo(dT)(12-18) |
33 |
| poly(rC)-oligo(dG) |
13 |
| poly(rC)-oligo(dG)(12-18) |
183 |
| poly(rC)500:oligo(dG)10 |
103 |
| Poly(rC):oligo(dG )Template:Primer |
50 |
| poly(rC):oligo(dG) |
313 |
| RNA template(1080) : deoxy-oligo primer(18) |
83 |
| RNA:Biotin-DNA template:primer |
10 |
| RNA:DNA template:primer |
70 |
| HIV-1 Reverse Transcriptase Mutant (103N/181C) |
poly rC/biotin-dG15 |
26 |
| RNA:Biotin-DNA template:primer |
10 |
| HIV-1 Reverse Transcriptase Mutant (G190A) |
poly(rC)500:oligo(dG)10 |
9 |
| HIV-1 Reverse Transcriptase Mutant (K103N) |
(poly)rC:(oligo)dG |
8 |
| (rC)n.(dG)12-18 |
22 |
| poly r(A).oligo d(T)16 |
5 |
| poly(rA)/oligo(dT) |
5 |
| poly(rC)-oligo(dG)(12-18) |
4 |
| poly(rC)500:oligo(dG)10 |
10 |
| Poly(rC):oligo(dG )Template:Primer |
50 |
| HIV-1 Reverse Transcriptase Mutant (K103N/Y181C) |
poly rC/biotin-dG15 |
11 |
| HIV-1 Reverse Transcriptase Mutant (L100I) |
(rC)n.(dG)12-18 |
47 |
| poly(rA)-oligo(dT) |
5 |
| poly(rA)/oligo(dT) |
4 |
| poly(rC)-oligo(dG)(12-18) |
5 |
| HIV-1 Reverse Transcriptase Mutant (L100I/K103N) |
poly(rA).oligo(dT)12-18 |
3 |
| HIV-1 Reverse Transcriptase Mutant (P236L) |
poly(rA)600:oligo(dT)10 |
43 |
| poly(rC)500:oligo(dG)10 |
10 |
| HIV-1 Reverse Transcriptase Mutant (V106A) |
poly(rA)/oligo(dT) |
3 |
| poly(rC)500:oligo(dG)10 |
9 |
| HIV-1 Reverse Transcriptase Mutant (V179D) |
poly(rA)/oligo(dT) |
5 |
| HIV-1 Reverse Transcriptase Mutant (Y181C) |
(poly)rC:(oligo)dG |
7 |
| (rC)n.(dG)12-18 |
69 |
| poly r(A).oligo d(T)16 |
4 |
| poly(rA)-oligo(dT) |
5 |
| poly(rA).oligo(dT)12-18 |
3 |
| poly(rA)600:oligo(dT)10 |
40 |
| poly(rC)-oligo(dG)(12-18) |
10 |
| poly(rC)500:oligo(dG)10 |
93 |
| Poly(rC):oligo(dG )Template:Primer |
46 |
| poly(rC):oligo(dG) |
63 |
| HIV-1 Reverse Transcriptase Mutant (Y181I) |
poly(rA)/oligo(dT) |
5 |
| HIV-1 Reverse Transcriptase Mutant (Y188L) |
poly(rA)/oligo(dT) |
3 |
| poly(rC)500:oligo(dG)10 |
59 |
| HIV-1 Reverse Transcriptase RNase H |
RNA/DNA hybrid |
374 |
| HIV-1 Reverse Transcriptase RNase H Mutant (D67N/K70R/T215F/K219Q) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (L100I/K103N) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (V106A/Y181C) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (Y181C) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (Y188L) |
RNA/DNA hybrid |
2 |
| HIV-2 Protease |
decapeptide substrate |
7 |
| HIV Protease Peptide Substrate |
13 |
| HIV-1 Protease substrate |
1 |
| Peptide Substrate |
1 |
| HIV-2 Reverse Transcriptase |
poly(rC)-oligo(dG)(12-18) |
3 |
| HIV-2 Reverse Transcriptase RNase H |
RNA/DNA hybrid |
2 |
| HMG-CoA Reductase |
HMG-CoA |
107 |
| Homoisocitrate Dehydrogenase (HICDH) |
Homoisocitrate |
12 |
| I-kappa-B Kinase 1 (IKK-alpha) |
I-kappa-B-alpha |
142 |
| I-kappa-B Kinase 2 (IKK-beta) |
Biotinylated I-kappa-B-alpha Peptide Substrate |
22 |
| I-kappa-B-alpha |
151 |
| I-kappa-B Kinase 3 (IKK-epsilon) |
I-kappa-B-alpha |
40 |
| Immunophilin FKBP12 |
N-succinyl Ala-Leu-Pro-Phe p-nitroanilide |
79 |
| IMP Cyclohydrolase (IMPCH) |
FAICAR |
3 |
| Indoleamine 2,3-Dioxygenase |
L-tryptophan |
108 |
| Inosine Monophosphate Dehydrogenase Type 1 (IMPDH1) |
IMP |
14 |
| Inosine Monophosphate Dehydrogenase Type 2 (IMPDH2) |
IMP |
40 |
| Insulin Receptor Tyrosine Kinase (IRK) |
Insulin Kinase Peptide Substrate |
5 |
| peptide 1150 |
1 |
| Peptide Substrate |
8 |
| poly Glu4: Tyr |
77 |
| polyGlu4Tyr |
4 |
| Insulin Receptor-Related Protein (INSRR) |
biotinylated affinity ligand |
6 |
| Insulin-like Growth Factor 1 Receptor (IGF-1R) |
biotinylated gastrin substrate |
2 |
| Biotinylated substrate peptide |
160 |
| Peptide Substrate |
8 |
| poly (Glu/Tyr) |
10 |
| Integrin alpha1beta1 |
Collagen IV |
5 |
| Integrin alpha2beta1 |
Collagen I |
33 |
| Integrin alpha4beta1 (VLA-4) |
biotinylated CS-1 peptide |
61 |
| Eu-Labeled Human VCAM-1/Fc Chimera |
42 |
| Tritiated 3H Standard Compound A |
44 |
| VCAM-1 |
101 |
| Integrin alpha4beta7 |
MAdCAM-1 |
71 |
| Integrin alpha5beta1 |
Fibronectin |
5 |
| Kallikrein |
benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin |
27 |
| Pefachrome FVIIa |
27 |
| Kappa Opioid Receptor |
[3H]-diprenorphine |
90 |
| [3H]U69593 |
5 |
| KIAA1363 |
FP-rhodamine |
1 |
| Kinesin Spindle Protein Eg5 |
ATP |
198 |
| KIT(D816V) |
biotinylated affinity ligand |
23 |
| KIT(V559D T670I) |
biotinylated affinity ligand |
19 |
| Kynurenine Aminotransferase 1/Glutamine Transaminase K |
Kynurenine |
2 |
| Lactate Dehydrogenase |
Lactate |
52 |
| Pyruvate |
16 |
| Lck |
biotinylated gastrin substrate |
60 |
| Biotinylated peptide substrate |
54 |
| Enolase |
78 |
| Gastrin Peptide Substrate |
35 |
| N-biotinyl peptide substrate |
1 |
| Not Specified |
1 |
| poly-Glu-Ala-Tyr |
16 |
| Leucine Aminopeptidase |
L-Leucine-para-nitroanilide |
19 |
| Leukotriene A4 Hydrolase |
Alanine para-nitroanilide |
75 |
| Leukotriene A4 |
42 |
| Lipoxygenase-1 |
Sodium linoleate |
8 |
| Liver Receptor Homolog 1 |
Biotinylated TIF2 Peptide |
23 |
| Liver X Receptor alpha (LXR-alpha) |
biotinylated SRC-1 peptide |
85 |
| GW3965 |
4 |
| Not Available |
18 |
| T0901317 |
39 |
| [3H]T0901317 |
76 |
| Liver X Receptor beta (LXR-beta) |
biotinylated SRC-1 peptide |
137 |
| GW3965 |
4 |
| Not Available |
18 |
| T0901317 |
39 |
| [3H]T0901317 |
74 |
| Malate Dehydrogenase (pfMDH) |
Oxaloacetic acid |
8 |
| Malate Dehydrogenase, cytoplasmic |
Oxaloacetic acid |
7 |
| Malate Dehydrogenase, mitochondrial |
Oxaloacetic acid |
9 |
| Mammalian Target of Rapamycin (mTOR) |
GFP-4EBP |
1 |
| S6K1 |
91 |
| MAP Kinase Kinase 1 (MEK1) |
biotin-MBP protein |
1 |
| MAP Kinase p38 alpha |
ATF-2-GST |
129 |
| biotinylated ATF2 substrate |
28 |
| biotinylated GST-ATF2 |
56 |
| biotinylated-ATF2 |
60 |
| Epidermal Growth Factor Receptor Peptide (EGFRP) |
12 |
| myelin basic protein |
136 |
| Not Available |
28 |
| Rhodamine-green Labelled Fluoroligand |
33 |
| SKF 86002 |
12 |
| Substrate Peptide T669 |
5 |
| MAP Kinase p38 alpha Mutant (G110A) |
biotinylated GST-ATF2 |
6 |
| MAP Kinase p38 alpha Mutant (G110D) |
biotinylated GST-ATF2 |
6 |
| MAP Kinase p38 beta |
biotinylated GST-ATF2 |
15 |
| MAP Kinase-Interacting Protein Kinase (MNK1) |
MBP |
4 |
| MAP-Microtubule Affinity-Regulating Kinase 3 (MARK3) |
CHKtide Substrate |
1 |
| MAP4K4 (HGK) |
Substrate Peptide SerThr 07 |
1 |
| MAPK-Activated Protein Kinase 2 (MK2) |
Biotinylated GST-LSP1 |
102 |
| HSP27 Peptide |
31 |
| Hsp27 Substrate Peptide |
17 |
| MAPK-Activated Protein Kinase 3 (MK3) |
Peptide Substrate |
4 |
| MAPK-Activated Protein Kinase 5 (MK5) |
Peptide Substrate |
4 |
| Matriptase |
Pefachrome tPA |
54 |
| t-Boc-Gln-Ala-Arg-AMC |
14 |
| Matrix Metalloproteinase-1 (MMP-1) |
Fluorescence-quenched peptide substrate |
1 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
27 |
| MMP Substrate Peptide |
3 |
| MMP Thioester Substrate |
91 |
| NFF-2 Substrate |
53 |
| OmniMMP Substrate |
2 |
| Unknown |
1 |
| Wammp-5 |
2 |
| Matrix Metalloproteinase-10 (MMP-10) |
Fluorescence-quenched peptide substrate |
1 |
| MMP Substrate Peptide |
3 |
| Matrix Metalloproteinase-12 (MMP-12) |
Fluorescence-quenched peptide substrate |
6 |
| MMP Fluorogenic Substrate |
32 |
| MMP Substrate Peptide |
20 |
| Not Available |
5 |
| OmniMMP Substrate |
2 |
| Wammp-5 |
4 |
| Matrix Metalloproteinase-13 (MMP-13) |
5-FAM/QXL 520 Peptide Substrate |
23 |
| Fluorescence-quenched peptide substrate |
1 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
27 |
| MMP Fluorogenic Substrate |
36 |
| MMP Substrate Peptide |
3 |
| MMP-13 Fluorogenic Peptide Substrate |
2 |
| MMP-13 Substrate |
64 |
| Wammp-5 |
51 |
| Matrix Metalloproteinase-14 (MMP-14) |
OmniMMP Substrate |
2 |
| Wammp-5 |
9 |
| Matrix Metalloproteinase-2 (MMP-2) |
5-FAM/QXL520 |
27 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
34 |
| MMP Substrate Peptide |
19 |
| MMP Thioester Substrate |
91 |
| OmniMMP Substrate |
2 |
| Unknown |
1 |
| Wammp-5 |
39 |
| Matrix Metalloproteinase-3 (MMP-3) |
MMP Fluorogenic Peptide Substrate |
7 |
| MMP Substrate Peptide |
19 |
| MMP-3 Fluorogenic Peptide Substrate |
19 |
| NFF-2 Substrate |
4 |
| Substance P |
62 |
| Matrix Metalloproteinase-7 (MMP-7) |
Fluorescence-quenched peptide substrate |
1 |
| MMP Substrate Peptide |
19 |
| OmniMMP Substrate |
2 |
| Wammp-5 |
7 |
| Matrix Metalloproteinase-8 (MMP-8) |
Fluorescence-quenched peptide substrate |
1 |
| MMP Fluorogenic Peptide Substrate |
18 |
| MMP Substrate Peptide |
3 |
| MMP Thioester Substrate |
91 |
| OmniMMP Substrate |
2 |
| Wammp-5 |
7 |
| Matrix Metalloproteinase-9 (MMP-9) |
5-FAM/QXL520 |
27 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
19 |
| MMP Substrate Peptide |
3 |
| MMP Thioester Substrate |
91 |
| NFF-2 Substrate |
4 |
| OmniMMP Substrate |
2 |
| Unknown |
1 |
| Wammp-5 |
8 |
| Mcl-1 |
FITC-conjugated-Bim BH3 Peptide |
10 |
| MEK Kinase 1 (MEKK1) |
MBP |
1 |
| Melanin-Concentrating Hormone Receptor 1 (MCH1R) |
[125I]-MCH |
21 |
| Methionine Aminopeptidase (MAP) |
Met-Gly-Met-Met |
14 |
| Met-Pro-pNA |
6 |
| Methionine Aminopeptidase Type 1 (MetAP1) |
Met-Pro-pNA |
5 |
| Octapeptide substrate |
9 |
| Methionine Aminopeptidase Type 2 (MetAP2) |
Met-AMC |
124 |
| Met-Pro-pNA |
5 |
| Octapeptide substrate |
159 |
| Methylthioadenosine Nucleosidase(MTAN) |
MTA |
6 |
| Methylthioadenosine Phosphorylase (MTAP) |
MTA |
3 |
| Mineralocorticoid Receptor (MR) |
Aldosterone |
11 |
| dexamethasone |
8 |
| dexamethasone (tetramethyl-rhodamine conjugated ) |
3 |
| Mitogen- and Stress-Activated Protein Kinase 1 (MSK1) |
Crosstide |
11 |
| Peptide Substrate |
4 |
| Mitogen- and Stress-Activated Protein Kinase 2 (MSK2) |
Peptide Substrate |
4 |
| Mitogen-Activated Protein Kinase 1 |
Myelin basic protein |
4 |
| Mitogen-Activated Protein Kinase 10 (JNK3) |
biotinylated GST-ATF2 |
10 |
| biotinylated-ATF2 |
47 |
| EGF receptor peptide |
29 |
| fluorescently labelled inhibitor |
4 |
| Rhodamine-green Labelled Fluoroligand |
4 |
| Mitogen-Activated Protein Kinase 8 (JNK1) |
ATF2 |
45 |
| Biotin-GST-c-JUN |
34 |
| Biotin-labeled pepJIP1 |
45 |
| biotinylated GST-ATF2 |
6 |
| biotinylated-ATF2 |
43 |
| GST-ATF2 |
149 |
| Mitogen-Activated Protein Kinase 9 (JNK2) |
biotinylated affinity ligand |
5 |
| biotinylated GST-ATF2 |
6 |
| GST-ATF2 |
69 |
| Mixed Lineage Kinase 1 (MLK1) |
Myelin basic protein |
37 |
| Mixed Lineage Kinase 2 (MLK2) |
Myelin basic protein |
8 |
| Mixed Lineage Kinase 3 (MLK3) |
Myelin basic protein |
37 |
| MKP-3 |
3-O-methylfluorescein phosphate (OMFP) |
45 |
| ML-IAP-BIR |
AVP-diPhe-FAM |
32 |
| Monoamine Oxidase Type A (MAO-A) |
5-hydroxy tryptamine creatinine disulfate |
79 |
| kinuramine |
34 |
| Kynuramine |
59 |
| p-Tyramine |
79 |
| Monoamine Oxidase Type B (MAO-B) |
benzylamine |
21 |
| kinuramine |
34 |
| Kynuramine |
38 |
| MMTP |
16 |
| p-Tyramine |
79 |
| phenylethylamine |
78 |
| Monoamine oxidase type B (MAO-B) Mutant (I199F) |
benzylamine |
5 |
| Monocarboxylate Transporter 1 |
[125I]-pyrrolo[3,4-d]pyridazin-1-one |
8 |
| [3H]-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione |
35 |
| Monoglyceride Lipase (MGL) |
2-arachidonoylglycerol (2-AG) |
21 |
| FP-rhodamine |
1 |
| MPI protein |
Mannose-6-phosphate |
462 |
| MRCK alpha |
S6-peptide |
5 |
| Mu Opioid Receptor |
[3H]-diprenorphine |
106 |
| [3H]DAMGO |
56 |
| MurD |
D-[14C]Glu |
37 |
| Myosin Light-Chain Kinase |
Myosin Light-Chain |
18 |
| NAD-Dependent Deacetylase Sirtuin-1 |
Fluor de Lys-SIRT1 |
21 |
| NAD-Dependent Deacetylase Sirtuin-2 |
Fluor de Lys-SIRT2 |
20 |
| Neuraminidase A |
neuraminidase substrate |
270 |
| Neuraminidase B |
neuraminidase substrate |
181 |
| Neutral Endopeptidase |
DGPA |
29 |
| Neutrophil Elastase (NE) |
N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methylcoumarin |
33 |
| Suc-Ala-Pro-Ala-MCA |
23 |
| Niacin Receptor GPR109A |
[5, 6-3H]-niacin |
18 |
| Nitric Oxide Synthase, brain |
L-arginine |
24 |
| Not Available |
30 |
| Nitric Oxide Synthase, brain Mutant (D597N) |
L-arginine |
3 |
| Nitric Oxide Synthase, brain Mutant (D597N/M336V) |
L-arginine |
4 |
| Nitric Oxide Synthase, endothelial |
L-arginine |
24 |
| Not Available |
32 |
| Nitric Oxide Synthase, endothelial Mutant (N368D) |
L-arginine |
3 |
| Nitric Oxide Synthase, inducible |
L-arginine |
14 |
| Not Available |
41 |
| NK1 Receptor |
Substance P |
23 |
| Nociceptin Receptor (ORL1 Receptor) |
leucyl-[3H]nociceptin |
21 |
| [125I]-nociceptin |
89 |
| [125I]Tyr14-Nociceptin |
58 |
| Norepinephrine Transporter (NET) |
[125I]RTI-55 |
29 |
| [3H]NE |
6 |
| [3H]Nisoxetine |
40 |
| Orotidine Monophosphate Decarboxylase (ODCase) |
OMP |
23 |
| p53-Binding Protein HDMX |
p53 Peptide |
25 |
| p53-Binding Protein MDM2 |
6-FAM labeled octapeptide |
20 |
| biotinylated IP3 peptide |
45 |
| biotinylated p53-derived peptide |
9 |
| Fl 9mer |
55 |
| GST-p53 |
1 |